In March 2018, Mark Landler — then a White House correspondent at The New York Times — attended a dinner party hosted by the United Arab Emirates’ ambassador, Yousef al-Otaiba, at a Washington restaurant. There he witnessed a chance encounter between the ambassador and Prime Minister Benjamin Netanyahu of Israel — one the ambassador asked to keep private. Two years after that delicate conversation, Israel and the United Arab Emirates have agreed to normalize diplomatic and trade relations. Today, we speak to Mr. Landler about the Trump administration’s role in the agreement, what normalization means for Palestinians and what it says about the Middle East’s political climate. Guest: Mark Landler, London bureau chief at The New York Times. For more information on today’s episode, visit nytimes.com/thedaily Background reading: The Arab Spring, growing power of Iranian proxies and demographic changes — how changing dynamics in the Middle East set the stage for the deal.The U.A.E. has agreed to normalization in exchange for Israel’s suspending annexation of areas in the occupied West Bank. Many Palestinians see the deal as less of a balm and more of a stab in the back.
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

Nachrichten
The Daily Folgen
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Also, for more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Folgen von The Daily
2596 Folgen
-
Folge vom 18.08.2020A Dinner and a Deal
-
Folge vom 17.08.2020Inside Operation Warp SpeedOperation Warp Speed has in some ways lived up to its name: The U.S. government has awarded almost $11 billion to seven different companies to develop vaccines, three of which — Moderna, AstraZeneca and Pfizer — are in late-stage trials.Things are going according to the most aggressive schedule.However, accelerating the development process has increased the likelihood of cronyism and undue political influence.Today, we ask whether the White House’s defiance of the timelines that have long governed the development of vaccines is working.Guest: Katie Thomas, a reporter at The New York Times who covers the health care sector, with a focus on the drug industry.For more information on today’s episode, visit nytimes.com/thedaily Background reading: There is a lot of optimism surrounding the coronavirus vaccine and its potential to usher in a return to normality in the near future — but doctors warn that those expectations ought to be tempered.With thousands dying, economic tumult and a looming election, the U.S. government is eager to start vaccinating as soon as possible. Experts worry that the Trump administration will push the Food and Drug Administration to overlook insufficient data.The vaccine effort has spelled big profits for corporate insiders. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
-
Folge vom 16.08.2020The Sunday Read: 'Unwanted Truths'What is the extent of Russia’s interest in the 2020 U.S. election? Last year, a classified report written by intelligence officials tried to answer this question.In this episode, Robert Draper, a writer-at-large at The New York Times Magazine, explores what happened after the report — which stated that President Trump was Russia’s favored candidate in the upcoming election — was drafted.This story was written by Robert Draper and recorded by Audm. To hear more audio stories from publishers like The New York Times, download Audm for iPhone or Android. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
-
Folge vom 14.08.2020Protesting Her Own Employer“As a Black woman who works at Adidas my experiences have never been business as usual.”Julia Bond, an assistant apparel designer at the sportswear giant, says she had resigned herself to experiencing and witnessing racism at work — until she saw the George Floyd video.Today, we speak to Ms. Bond, an assistant apparel designer at Adidas, who has brought the global racial reckoning to the company’s front door.Wanting more than just schemes and targets, she has been protesting in front of the company’s Portland headquarters every day since June, awaiting an apology from leadership and an admission that they have enabled racism and discrimination. Guest: Julia Bond, assistant apparel designer at Adidas, who has been protesting outside the company’s Portland headquarters for the last three months. For more information on today’s episode, visit nytimes.com/thedaily. Background reading: Adidas has made a number of pledges to diversify its work force. However, Black employees want more: an admission that the company’s leadership has enabled racism and an apology. From Facebook’s pledge to double the number of Black and Latinx by 2023 to YouTube creating a $100 million fund for Black creators, organizations across the U.S. have committed to redressing racial imbalance. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.